The deal will not only add to Pfizer’s EPS, but will also provide to stronger traction in the cancer drugs market. U.S. pharmaceutical giant Pfizer Inc stated it would acquire Array Biopharma Inc for $10.64 billion in cash. The potential… Read More ›